List of the List of the ““bullet pointsbullet points””in the first FP7 calls for proposalsin the first FP7 calls for proposalsof direct relevance toof direct relevance tonanotechnologynanotechnology
Disclaimer: Note that this compilation is not legally binding and does not represent any commitment on behalf of the European Commission
NMP571
IST466
Marie Curie149
Infrastructures40
Health65
NEST22
SME17
other32
Background: Nanotechnology R&D in FP6Background: Nanotechnology R&D in FP6More than 1.3 billion€ in more than 550 projects
EC funding by FP6 programme, M€
ERANET Plus in nanosciencesNMP-2007-1.1-5CSA (ERANET)
Development of methodology, collection and elaboration of scientific-technical and socio-economic data and studies on nanosciences and nanotechnologies, including risk assessment, and establishment of an observatory
NMP-2007-1.1-4CSA
Support to ICPC researchers in nanotechnology and creation of a free and open electronic archive of nanosciences and nanotechnologies scientific and technical publications
NMP-2007-1.1-3CSA
Self-assembling and self-organisation NMP-2007-1.1-2CP
Nano-scale mechanisms of bio/non-bio interactions NMP-2007-1.1-1CP
Funding for Nanotechnology R&D in FP7Funding for Nanotechnology R&D in FP7• More than 50 activities in the calls opened in 2007 are directly relevant• Many more activities are indirectly relevant (e.g. in Health)• 300-400M€ estimated in 2007•• Doubling of the FP6 funding expected over duration of FP7
NanoscienceNanoscience
Application of new materials including bio-based fibres in high-added value textile products
NMP-2007-4.0-2SME-targeted CP
Production Technologies and equipment for Micro-Manufacturing NMP-2007-3.5-2Large CP
Examining capacity building in nanobiotechnologyNMP-2007-1.2-5CSA
Processes and Equipment for High Quality Industrial Production of 3-Dimensional Nanosurfaces
NMP-2007-3.5-1Large CP
Rapid Manufacturing Concepts for Small Series Industrial Production NMP-2007-3.4-1SME-targeted CP
Coordination in nanometrologyNMP-2007-1.2-4CSA
Analysis of the ethical, regulatory, social and economic environment of nanomedicine
NMP-2007-1.2-3CSA
Equipment and methods for nanotechnology NMP-2007-1.2-2SME-targeted CP
Pilot lines to study, develop and up-scale nanotechnology-based processes from laboratory
NMP-2007-1.2-1Large CP
Technology developmentTechnology development
Science in Society: Nanoscience and NanotechnologySiS-2007-1.2.3.2-CTCSA
Alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics
HEALTH-2007-1.3-4CP
Coordination in studying the environmental, safety and health impact of engineered nanoparticles and nanotechnology based materials and products
NMP-2007-1.3-5CSA
Creation of a critical and commented database on the health, safety and environmental impact of nanoparticles
NMP-2007-1.3-4CSA
Scientific review on the data and studies on the potential impact on health, safety and the environment of engineered nanoparticles
NMP-2007-1.3-3CSA
Risk assessment of engineered nanoparticles on health and the environment
NMP-2007-1.3-2CP
Specific, easy-to-use portable devices for measurement and analysis NMP-2007-1.3-1Large CP
Impact assessment and societal issuesImpact assessment and societal issues
Modelling of microstructural evolution under work conditions and in materials processing
NMP-2007-2.5-2CP
Renewable materials for functional packaging applications NMP-2007-2.4-3CP
Nanostructured catalysts with tailor-made functional surfaces NMP-2007-2.4-2CP
Highly porous bioactive scaffolds controlling angiogenesis for tissue engineering
NMP-2007-2.3.-1 Large CP
Advanced material architectures for energy conversion NMP-2007-2.2.-3CP
Nanostructured materials with tailored magnetic properties NMP-2007-2.2-2CP
Organic materials for electronics and photonicsNMP-2007-2.2-1Large CP
Characterisation of nanostructured materials NMP-2007-2.1.3CSA
Nanostructured coatings and thin films NMP-2007-2.1.2CP
Nanostructured polymer-matrix compositesNMP-2007-2.1.1Large CP
NanomaterialsNanomaterials
New materials and processes for advanced electrolysersENERGY-2007.1.2.1CP
Novel nanostructured materials for hydrogen storageENERGY-2007.1.2.4CP
Basic research for materials and processes for Polymer Electrolyte Membrane Fuel Cells (PEMFC)
ENERGY-2007.1.1.1CP
Basic research on materials and processes for High Temperature Fuel Cells (SOFC & MCFC)
ENERGY-2007.1.1.2CP
New materials and processes for advanced multi-fuel processorsENERGY-2007.1.2.2CP
AerostructuresAAT-2007.1.1.2CP, CSA
NanomaterialsNanomaterials ––contcont’’dd
Nano-scale ICT devices and systemsICT-2007.8.1CP, CSA (CA only)
Next generation nanoelectronics components and electronics integrationICT-2007.3.1CP, NoE, CSA
NanoelectronicsNanoelectronics
Development of emerging gene therapy tools and technologies for clinical application
HEALTH-2007-1.4.4Large CP 2nd call
Personal Health Systems for Monitoring and Point-of-Care diagnosticsICT-2007-5.1Large CP, CSA
Novel targeted imaging probes for early in vivo diagnosis and/orevaluation of response to therapy
HEALTH-2007-1.2.3Large CP
Substantial innovation in the European medical industry: development of nanotechnology-based systems for in-vivo diagnosis and therapy (in coordination with topics HEALTH-2007-2.4.1-7 and HEALTH-2007-1.2-3)
NMP-2007-4.0-4Large CP
Improving targeted drug delivery to cancer cells for cancer therapeutics other than gene therapy
HEALTH-2007-2.4.1-7CP
NanomedicineNanomedicine
NB: Many more activities in the Health theme are relevant to nanomedicine,e.g. imaging, stem cells and translating research for human health
Life-cycle[of air vehicles, including increased use of nanotechnologies]
AAT-2007.6.1.4CP, CSA
Photonic components and subsystemsICT-2007.3.5CP, NoE, CSA 2nd call
Micro/nanosystemsICT-2007.3.6CP, NoE, CSA 2nd call
Nano-devices for quality assurance, food safety and product propertiesKBBE-2007-2-3-04CP
Innovative and safe packagingKBBE-2007-2-4-04CP
Converging technologies and their potential for the food areaKBBE-2007-2-5-02CP
FET (Future and Emerging Technologies) Open(Open call for bottom-up activities)
ICT-2007-CCP, CSA (CA only)
Other Important TopicsOther Important Topics
Please consider also opportunities withinCOST actions (funding for co-ordination activities)http://www.cost.esf.org/
Ideas Ideas –– European Research CouncilEuropean Research Council
Human ResourcesHuman Resources
Infrastructures & Infrastructures & SMEsSMEs
Marie Curie Awards(all research areas)
PEOPLE-2007-5-2-Awards
Marie Curie Initial Training Networks(all research areas)
PEOPLE-2007-1-1-ITN
ERC Advanced Investigator Grants(all research areas)Expected in 2nd call
ERC Starting Independent Researcher Grants(all research areas)
ERC-2007-StG
Please consider also the opportunities in educational programmes managed by DG EAChttp://ec.europa.eu/education/programmes/programmes_en.html
Research for the benefit of SMEsFP7-SME-2007-1
PRINS, Pan-European Research Infrastructures for Nano-structures (from 2006 ESFRI Roadmap)
INFRA-2007-2.2.1.27Combination CP/CSA
References
http://http://cordis.europa.eu/nanotechnology/src/eu_funding.htmcordis.europa.eu/nanotechnology/src/eu_funding.htm
FP7: FP7: http://cordis.europa.eu/fp7/home_en.htmlFP7 calls:FP7 calls: http://cordis.europa.eu/fp7/dc/index.cfm
Nanotechnology homepage:Nanotechnology homepage:http://http://cordis.europa.eucordis.europa.eu/nanotechnology//nanotechnology/
Nanosciences and Nanotechnologies:Nanosciences and Nanotechnologies:An Action Plan for Europe 2005An Action Plan for Europe 2005--20092009
http://http://cordis.europa.eu/nanotechnology/actionplan.htmcordis.europa.eu/nanotechnology/actionplan.htm
Additional informationAdditional informationon nanotechnology: on nanotechnology: http://nanoforum.orghttp://nanoforum.org
The European Policy in Nanotechnology:The European Policy in Nanotechnology:integratedintegrated, , safesafe and and responsibleresponsible
Researchand
Development
Societal Issues
Infrastructure
HumanResources
IndustrialInnovation
InternationalCo-operation
Health, safety, environmental and consumer
protection
http://cordis.europa.eu.int/nanotechnology/actionplan.htm